News & Publications

News

Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101

Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101 September 26, 2019 12:00 PM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Curevo, Inc., a Seattle-based biotechnology company invested in by GC Pharma, one of the largest therapeutic protein manufacturers in the world, has announced encouraging preliminary Phase I safety and

Read More
News

GC Pharma to Establish Curevo

GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines GC Pharma, IDRI and MIBR Bringing Together to Develop Innovative Vaccines GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. (“Curevo”).

Read More